The main challenge in testing Alzheimer`s drugs in clinical trials is that participants need to have symptoms. But once people have symptoms, it is usually too late for treatments to have a significant effect, as many brain cells have already died.
from Zee News :Zee News - Health https://ift.tt/38M9B6D
via IFTTT
Subscribe to:
Post Comments (Atom)
Major Swedish study links rare pregnancy infections to 3-fold risk of autism
A Swedish study of 3.7 million people found that rare congenital TORCH infections were associated with substantially higher risks of autism...
-
A new diet trend called the 'Switch On' diet is taking social media by storm after a woman claimed to have lost 4 kg in just 6 days ...
-
Nipah Virus Detected In Kolkata: Two cases of Nipah virus have been detected in the state. Both the affected individuals are medical staffer...
No comments:
Post a Comment